161 related articles for article (PubMed ID: 1704250)
1. Tenascin expression in hyperproliferative skin diseases.
Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie EJ
Br J Dermatol; 1991 Jan; 124(1):13-20. PubMed ID: 1704250
[TBL] [Abstract][Full Text] [Related]
2. In-vitro DNA synthesis of keratinocytes in normal human skin, psoriasis, seborrhoeic keratosis, Bowen's disease and basal cell carcinoma.
Morimoto Y; Saga K; Bando M; Takahashi M
Br J Dermatol; 1991 Jul; 125(1):9-13. PubMed ID: 1831385
[TBL] [Abstract][Full Text] [Related]
3. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
4. The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.
Anbazhagan R; Sakakura T; Gusterson BA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(1):59-63. PubMed ID: 1696042
[TBL] [Abstract][Full Text] [Related]
5. Tenascin expression in human dermis is related to epidermal proliferation.
Schalkwijk J; Steijlen PM; van Vlijmen-Willems IM; Oosterling B; Mackie EJ; Verstraeten AA
Am J Pathol; 1991 Nov; 139(5):1143-50. PubMed ID: 1719820
[TBL] [Abstract][Full Text] [Related]
6. Normal human skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal proliferation (Ki-67 binding).
Rulo HF; van Vlijmen-Willems IM; Schalkwijk J; Verstraeten AA; van de Kerkhof PC
J Dermatol Sci; 1993 Feb; 5(1):54-7. PubMed ID: 7683489
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
9. Expression of tenascin, biglycan and decorin in disorders of keratinization.
Steijlen PM; Maessen E; Kresse H; Van Vlijmen IM; Verstraeten AA; Traupe H; Schalkwijk J
Br J Dermatol; 1994 May; 130(5):564-8. PubMed ID: 7515636
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
Takeda A; Nonaka M; Ishikawa A; Higuchi D
Arch Dermatol Res; 1999 Apr; 291(4):238-40. PubMed ID: 10335922
[No Abstract] [Full Text] [Related]
11. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
12. Expression of the 27-kDa heat shock protein in human epidermis and in epidermal neoplasms: an immunohistological study.
Trautinger F; Kindas-Mügge I; Dekrout B; Knobler RM; Metze D
Br J Dermatol; 1995 Aug; 133(2):194-202. PubMed ID: 7547384
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
14. Tenascin distribution in basal cell carcinomas.
Stamp GW
J Pathol; 1989 Nov; 159(3):225-9. PubMed ID: 2480437
[TBL] [Abstract][Full Text] [Related]
15. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
[TBL] [Abstract][Full Text] [Related]
16. Expression of bcl-6 protein in normal skin and epidermal neoplasms.
Kanazawa N; Moriyama M; Onizuka T; Sugawara K; Mori S
Pathol Int; 1997 Sep; 47(9):600-7. PubMed ID: 9311010
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
Jang TJ
Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
[TBL] [Abstract][Full Text] [Related]
18. Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression.
Komine M; Okinaga M; Takeda F; Nashiro K; Kikuchi K; Murakami T; Soma Y; Tamaki K
Br J Dermatol; 2001 Aug; 145(2):223-8. PubMed ID: 11531783
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of tenascin in benign eccrine gland tumors: comparison with laminin and fibronectin.
Mori M; Shrestha P; Takagi H; Ogata K; Takai Y
J Dermatol Sci; 1995 Mar; 9(2):123-8. PubMed ID: 7539630
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-fos proto-oncogene mRNA in non-melanoma skin cancer.
Takahashi S; Pearse AD; Marks R
J Dermatol Sci; 1994 Feb; 7(1):54-62. PubMed ID: 8193084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
